| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.86e-04 | 13 | 33 | 2 | GO:1990907 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.14e-04 | 10 | 23 | 2 | MM15156 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.29e-04 | 14 | 23 | 2 | M27402 | |
| Pubmed | 3.33e-05 | 9 | 34 | 2 | 32869873 | ||
| Pubmed | 4.20e-05 | 401 | 34 | 5 | 25852190 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 6.08e-05 | 12 | 34 | 2 | 11266540 | |
| Pubmed | 1.37e-04 | 102 | 34 | 3 | 10231032 | ||
| Pubmed | 1.69e-04 | 285 | 34 | 4 | 34369648 | ||
| Pubmed | 2.12e-04 | 22 | 34 | 2 | 8673525 | ||
| Pubmed | Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation. | 2.12e-04 | 22 | 34 | 2 | 9109416 | |
| Pubmed | 2.12e-04 | 22 | 34 | 2 | 11530211 | ||
| Pubmed | 2.32e-04 | 23 | 34 | 2 | 1736542 | ||
| Pubmed | 2.32e-04 | 23 | 34 | 2 | 8093218 | ||
| Pubmed | Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. | 2.32e-04 | 23 | 34 | 2 | 3099781 | |
| Pubmed | Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. | 2.32e-04 | 23 | 34 | 2 | 3264072 | |
| Pubmed | 3.45e-04 | 28 | 34 | 2 | 9714600 | ||
| Pubmed | Many sequence variants affecting diversity of adult human height. | 3.71e-04 | 143 | 34 | 3 | 18391951 | |
| Pubmed | Specification of dopaminergic subsets involves interplay of En1 and Pitx3. | 4.24e-04 | 31 | 34 | 2 | 23863478 | |
| Pubmed | 4.43e-04 | 152 | 34 | 3 | 11044609 | ||
| Pubmed | 5.72e-04 | 36 | 34 | 2 | 9344654 | ||
| Pubmed | 6.05e-04 | 37 | 34 | 2 | 2542563 | ||
| Pubmed | 6.05e-04 | 37 | 34 | 2 | 2541446 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 6.37e-04 | 1105 | 34 | 6 | 35748872 | |
| Pubmed | 6.38e-04 | 38 | 34 | 2 | 2829950 | ||
| Pubmed | Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. | 6.38e-04 | 38 | 34 | 2 | 2187500 | |
| Pubmed | 6.49e-04 | 407 | 34 | 4 | 12693553 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 7.56e-04 | 424 | 34 | 4 | 21731673 | |
| Pubmed | 8.17e-04 | 43 | 34 | 2 | 25130324 | ||
| Pubmed | Glycosylation and processing of the human immunodeficiency virus type 1 envelope protein. | 9.35e-04 | 46 | 34 | 2 | 2649653 | |
| Pubmed | 9.75e-04 | 47 | 34 | 2 | 15009096 | ||
| Cytoband | 7q21 | 4.13e-05 | 13 | 34 | 2 | 7q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q22 | 5.74e-04 | 219 | 34 | 3 | chr7q22 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.23e-06 | 151 | 34 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.05e-05 | 180 | 34 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| Drug | citronellyl alpha-D-mannopyranosyl phosphate | 1.30e-05 | 4 | 34 | 2 | CID000191367 | |
| Drug | Man)5(GlcNAc)2Asn | 1.30e-05 | 4 | 34 | 2 | CID003082495 | |
| Drug | (2S,3S,4R,5R,6S)-2,6-difluoro-2-(hydroxymethyl)oxane-3,4,5-triol | 2.16e-05 | 5 | 34 | 2 | CID010013013 | |
| Disease | cervical carcinoma | 9.14e-04 | 182 | 31 | 3 | EFO_0001061 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 1.13e-03 | 766 | 31 | 5 | EFO_0004713, GO_0097366 | |
| Disease | initial pursuit acceleration | 3.78e-03 | 87 | 31 | 2 | EFO_0008434 | |
| Disease | lymphocyte percentage of leukocytes | 4.96e-03 | 665 | 31 | 4 | EFO_0007993 | |
| Disease | neurotic disorder | 5.06e-03 | 101 | 31 | 2 | EFO_0004257 | |
| Disease | Bell's palsy | 5.15e-03 | 102 | 31 | 2 | EFO_0007167 | |
| Disease | smoking behavior | 5.41e-03 | 341 | 31 | 3 | EFO_0004318 | |
| Disease | neuritic plaque measurement | 5.77e-03 | 349 | 31 | 3 | EFO_0006798 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGMLEVFVAPTHHPH | 771 | P53355 | |
| HIMIYNVHAPPHGDQ | 86 | Q6ZS02 | |
| VHPSHHPEIMRLFPR | 271 | Q8NFV4 | |
| PFSGDPHMVSVHIHF | 881 | Q13367 | |
| PGDESPVVMHHHGRH | 41 | O00189 | |
| MMHAPRCGVPDVHHF | 86 | P39900 | |
| AHHIIAGRLMVIHAP | 161 | Q9UBM8 | |
| PFIPIHHMEAHALTI | 141 | Q9H4B0 | |
| LAVMVHPDKNHHPRA | 466 | Q6Y2X3 | |
| FEHMHHIPAPRPEEF | 246 | Q96F46 | |
| HRYGHSAPPFVHIIM | 276 | Q8NH61 | |
| RPAMEGPHTVHVAFA | 441 | Q14315 | |
| APHAIERLHHMHIYP | 1821 | Q8TDM6 | |
| HVYPDHRLVDPHIEM | 521 | Q86TG7 | |
| HRLVDPHIEMIPGAH | 526 | Q86TG7 | |
| THVNGEPVHGMVHPE | 1021 | Q9Y2H9 | |
| EYQGQPVVSHPHHIM | 321 | Q75N03 | |
| TPMVHHIRRFVHGQG | 1276 | Q9Y2I7 | |
| HLPEHEVMPHYRRLV | 616 | Q8TDN4 | |
| PLMHRLAHVENVFHP | 226 | O60941 | |
| PIRAFVVPHSHMDVG | 26 | Q9Y2E5 | |
| HFHPRNGLHHQVPVM | 141 | Q49AJ0 | |
| GMAIIRPPGHHAQHS | 206 | Q9UBN7 | |
| HRGHYPIGHEAPRML | 551 | Q8N4N8 | |
| GQPPHEHEMLRHPVF | 1481 | Q9P2R6 | |
| EHSVMPAQIHPHHLG | 136 | Q15319 | |
| GHPDVHIMQHHVLPI | 116 | Q9BXP5 | |
| RPAHILNPHHLEGDM | 996 | Q9Y4E5 | |
| MEKPHGHVSAHPDIL | 91 | Q99973 | |
| VVQHPHHMHPLTPLI | 181 | Q9HCS4 | |
| VVGFDPHHHMRVPAI | 421 | Q04727 | |
| MQPSGHRLRDVEHHP | 1 | Q9NXF8 | |
| FIGDHVHGAPHAVMP | 6 | Q6P280 | |
| PHRPVMMVISHAAPH | 211 | Q8IWU6 | |
| MVHFLHPGHTPRNIV | 1 | Q6WRX3 |